JPH10245390A5 - - Google Patents

Info

Publication number
JPH10245390A5
JPH10245390A5 JP1997061875A JP6187597A JPH10245390A5 JP H10245390 A5 JPH10245390 A5 JP H10245390A5 JP 1997061875 A JP1997061875 A JP 1997061875A JP 6187597 A JP6187597 A JP 6187597A JP H10245390 A5 JPH10245390 A5 JP H10245390A5
Authority
JP
Japan
Prior art keywords
group
hydroxy
positions
lower alkoxy
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997061875A
Other languages
English (en)
Japanese (ja)
Other versions
JP3536574B2 (ja
JPH10245390A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP06187597A priority Critical patent/JP3536574B2/ja
Priority claimed from JP06187597A external-priority patent/JP3536574B2/ja
Publication of JPH10245390A publication Critical patent/JPH10245390A/ja
Application granted granted Critical
Publication of JP3536574B2 publication Critical patent/JP3536574B2/ja
Publication of JPH10245390A5 publication Critical patent/JPH10245390A5/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP06187597A 1997-02-28 1997-02-28 抗腫瘍性インドロピロロカルバゾール誘導体 Expired - Fee Related JP3536574B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP06187597A JP3536574B2 (ja) 1997-02-28 1997-02-28 抗腫瘍性インドロピロロカルバゾール誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP06187597A JP3536574B2 (ja) 1997-02-28 1997-02-28 抗腫瘍性インドロピロロカルバゾール誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003351296A Division JP4155150B2 (ja) 2003-10-09 2003-10-09 抗腫瘍性新規インドロピロロカルバゾール誘導体

Publications (3)

Publication Number Publication Date
JPH10245390A JPH10245390A (ja) 1998-09-14
JP3536574B2 JP3536574B2 (ja) 2004-06-14
JPH10245390A5 true JPH10245390A5 (enExample) 2004-10-14

Family

ID=13183755

Family Applications (1)

Application Number Title Priority Date Filing Date
JP06187597A Expired - Fee Related JP3536574B2 (ja) 1997-02-28 1997-02-28 抗腫瘍性インドロピロロカルバゾール誘導体

Country Status (1)

Country Link
JP (1) JP3536574B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703373B1 (en) * 1999-09-10 2004-03-09 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives and antitumor agents
WO2001062769A1 (fr) 2000-02-24 2001-08-30 Banyu Pharmaceutical Co., Ltd. Procede de preparation de derives d'indolopyrrolocarbazole, leurs intermediaires, et procede de preparation des intermediaires
KR20040097237A (ko) 2002-03-26 2004-11-17 반유 세이야꾸 가부시끼가이샤 항종양성 인돌로피롤로카바졸 유도체와 기타 항암제의 병용
AU2003248104A1 (en) * 2003-07-24 2005-02-14 Banyu Pharmaceutical Co., Ltd. Crystalline 6-n-pyridylmethylaminoindolocarbazoles
AU2003248103A1 (en) * 2003-07-24 2005-02-14 Banyu Pharmaceutical Co., Ltd Indolopyrrolocarbazole derivative and antitumor agent
EP1666485A1 (en) * 2003-09-16 2006-06-07 Banyu Pharmaceutical Co., Ltd. Novel indolopyrrolocarbazole derivative with antitumor activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0528030B1 (en) 1990-05-11 1997-09-17 Banyu Pharmaceutical Co., Ltd. Antitumor be-13793c derivative
WO1995030682A1 (en) 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
AU3086495A (en) 1994-08-02 1996-03-04 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazoles

Similar Documents

Publication Publication Date Title
CA2302445A1 (en) New taxane derivatives
RU93043106A (ru) Способ получения производных таксана, производные таксана, фармацевтическая композиция на их основе, способ лечения, производные оксазолидина и способ получения производных оксазолидина
JP2002332234A5 (enExample)
CA2475113A1 (en) Isothiazole derivatives useful as anticancer agents
RU2000119792A (ru) Моносульфат азепептидного производного и содержащая его фармацевтическая композиция, ингибирующая вич-протеазу
EP0711768A4 (en) BENZIMIDAZOLE DERIVATIVES
JP2004533444A5 (enExample)
PL349839A1 (en) Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
CA2163837A1 (en) Crystalline Paclitaxel Hydrates
JP2002541233A5 (enExample)
EP0339842A3 (en) Novel oligoribonucleotide derivatives and application thereof to antiviral agents
CA2259977A1 (en) Taxane derivatives and drugs containing the same
CA2415010A1 (en) Propane-1,3-dione derivatives useful as gnrh receptor antagonist
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
CA2386828A1 (en) Novel pseudoerythromycin derivatives
TR200201102T2 (tr) Yeni oligosakkaritler, bunların hazırlanması ve bunları içeren ilaç bileşimleri
JP2000159790A5 (enExample)
EP0992509A3 (en) Novel macrolide derivatives
CA2673449A1 (en) A combination comprising combretastatin and anticancer agents
IL98262A (en) Chromone derivatives and pharmaceutical compositions containing them
CA2112084A1 (en) Antidepressant and antiparkinsonian compounds
CA2012955A1 (en) Antitumor substance be-13793c
CA2263353A1 (en) Arylsulfonylimidazolone derivatives as an antitumor agent
CA2219311A1 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives, method for their production and pharmaceutical compositions containing them
CA2272014A1 (en) N-aryl/heteroaryl-substituted heterocycles